Diabetes Drugs Go Head-to-Head in Study

Metformin outperforms widely used sulfonylureas, but each patient will be different, experts say

HealthDay SHARE

Although the study was not funded by pharmaceutical companies, several of the study authors do have ties to different drug companies, including GlaxoSmithKline, which makes Avandia, and Takeda Pharmaceuticals, which makes Actos.

More information

The American Diabetes Association has more on type 2 diabetes.

Copyright © 2011 HealthDay. All rights reserved.